questionsmedicales.fr
Maladies de l'appareil respiratoire
Maladies pulmonaires
Poumon hyperclair
Poumon hyperclair : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Radiographie
Scanner
Poumon hyperclair
Tomodensitométrie
Tests fonctionnels respiratoires
Densité pulmonaire
Radiologie
Hyperinflation
Physiologique
Anamnèse
Maladies respiratoires
Symptômes
5
Dyspnée
Toux
Douleurs thoraciques
Douleurs thoraciques
Maladies sous-jacentes
Enfants
Symptômes respiratoires
Toux
Causes sous-jacentes
Asymptomatique
Hyperinflation
Prévention
5
Prévention
Tabagisme
Polluants environnementaux
Vaccination
Grippe
Pneumocoque
Surveillance
Tests de fonction pulmonaire
Exercices respiratoires
Capacité pulmonaire
Habitudes de vie
Alimentation équilibrée
Traitements
5
Traitement
Bronchodilatateurs
Asthme
Antibiotiques
Infection bactérienne
Corticostéroïdes
Inflammation
Thérapies respiratoires
Bronchodilatateurs
Complications
5
Complications
Pneumothorax
Insuffisance respiratoire
Infections pulmonaires
Hyperinflation
Risques à long terme
Fonction pulmonaire
Facteurs de risque
5
Facteurs de risque
Tabagisme
Polluants
Asthme
BPCO
Maladies pulmonaires
Mode de vie
Sédentarité
Alimentation
Allergies
Problèmes pulmonaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Poumon hyperclair : Questions médicales les plus fréquentes",
"headline": "Poumon hyperclair : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Poumon hyperclair : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-19",
"dateModified": "2025-05-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Poumon hyperclair"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies pulmonaires",
"url": "https://questionsmedicales.fr/mesh/D008171",
"about": {
"@type": "MedicalCondition",
"name": "Maladies pulmonaires",
"code": {
"@type": "MedicalCode",
"code": "D008171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Poumon hyperclair",
"alternateName": "Lung, Hyperlucent",
"code": {
"@type": "MedicalCode",
"code": "D019568",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hiromichi Niikawa",
"url": "https://questionsmedicales.fr/author/Hiromichi%20Niikawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan."
}
},
{
"@type": "Person",
"name": "Kenneth R McCurry",
"url": "https://questionsmedicales.fr/author/Kenneth%20R%20McCurry",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA."
}
},
{
"@type": "Person",
"name": "Joshua M Diamond",
"url": "https://questionsmedicales.fr/author/Joshua%20M%20Diamond",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "Hisashi Oishi",
"url": "https://questionsmedicales.fr/author/Hisashi%20Oishi",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp."
}
},
{
"@type": "Person",
"name": "Takashi Hirama",
"url": "https://questionsmedicales.fr/author/Takashi%20Hirama",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neuropsychology and Movement Disorders.",
"datePublished": "2024-06-17",
"url": "https://questionsmedicales.fr/article/39343477",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ncl.2024.05.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cannabinoids in movement disorders.",
"datePublished": "2022-08-24",
"url": "https://questionsmedicales.fr/article/36038457",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.08.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Moving Beyond Movement: Diagnosing Functional Movement Disorder.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36893796",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1763505"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impaired Metacognition of Voluntary Movement in Functional Movement Disorder.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36606550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mds.29303"
}
},
{
"@type": "ScholarlyArticle",
"name": "Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35787539",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WCO.0000000000001075"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies pulmonaires",
"item": "https://questionsmedicales.fr/mesh/D008171"
},
{
"@type": "ListItem",
"position": 4,
"name": "Poumon hyperclair",
"item": "https://questionsmedicales.fr/mesh/D019568"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Poumon hyperclair - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Poumon hyperclair",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Poumon hyperclair",
"description": "Comment diagnostiquer un poumon hyperclair ?\nQuels examens complémentaires sont utiles ?\nQuels signes radiologiques indiquent un poumon hyperclair ?\nLe poumon hyperclair est-il toujours pathologique ?\nQuel rôle joue l'anamnèse dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Movement+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Poumon hyperclair",
"description": "Quels symptômes sont associés au poumon hyperclair ?\nLe poumon hyperclair provoque-t-il des douleurs ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nComment la toux se manifeste-t-elle ?\nLe poumon hyperclair est-il asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Movement+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Poumon hyperclair",
"description": "Comment prévenir le poumon hyperclair ?\nY a-t-il des vaccinations recommandées ?\nComment surveiller la santé pulmonaire ?\nLes exercices respiratoires aident-ils ?\nQuelles habitudes de vie adopter ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Movement+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Poumon hyperclair",
"description": "Quel traitement pour un poumon hyperclair ?\nLes antibiotiques sont-ils nécessaires ?\nQuand envisager une intervention chirurgicale ?\nLes corticostéroïdes sont-ils efficaces ?\nComment gérer les symptômes respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Movement+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Poumon hyperclair",
"description": "Quelles complications peuvent survenir ?\nLe poumon hyperclair peut-il entraîner des infections ?\nComment gérer les complications ?\nLe poumon hyperclair est-il réversible ?\nQuels sont les risques à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Movement+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Poumon hyperclair",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes maladies pulmonaires prédisposent-elles ?\nLe mode de vie joue-t-il un rôle ?\nLes allergies sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Movement+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un poumon hyperclair ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par radiographie thoracique et éventuellement par scanner."
}
},
{
"@type": "Question",
"name": "Quels examens complémentaires sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests fonctionnels respiratoires et une tomodensitométrie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes radiologiques indiquent un poumon hyperclair ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diminution de la densité pulmonaire et une augmentation de la transparence sont observées."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il toujours pathologique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il peut être physiologique chez les jeunes enfants ou en cas d'hyperinflation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'anamnèse dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anamnèse aide à identifier des antécédents de maladies respiratoires ou d'exposition."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés au poumon hyperclair ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure une dyspnée, une toux ou des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair provoque-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas directement, mais des douleurs peuvent survenir en raison de maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes respiratoires aigus ou chroniques."
}
},
{
"@type": "Question",
"name": "Comment la toux se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La toux peut être sèche ou productive, selon la cause sous-jacente du poumon hyperclair."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il asymptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être asymptomatique, surtout dans les cas d'hyperinflation bénigne."
}
},
{
"@type": "Question",
"name": "Comment prévenir le poumon hyperclair ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et les polluants environnementaux peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccinations recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre la grippe et le pneumocoque est conseillée."
}
},
{
"@type": "Question",
"name": "Comment surveiller la santé pulmonaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de fonction pulmonaire sont recommandés."
}
},
{
"@type": "Question",
"name": "Les exercices respiratoires aident-ils ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent améliorer la capacité pulmonaire et la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie adopter ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée et faire de l'exercice régulièrement est bénéfique."
}
},
{
"@type": "Question",
"name": "Quel traitement pour un poumon hyperclair ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des bronchodilatateurs pour l'asthme."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont nécessaires que si une infection bactérienne est suspectée."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de complications graves comme un pneumothorax."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés pour réduire l'inflammation dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes respiratoires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bronchodilatateurs et des thérapies respiratoires peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme le pneumothorax ou l'insuffisance respiratoire peuvent se produire."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair peut-il entraîner des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperinflation peut prédisposer à des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion dépend de la complication, nécessitant parfois une hospitalisation."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il réversible ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la cause; certaines conditions peuvent être réversibles avec un traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent une détérioration de la fonction pulmonaire et des complications chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à des polluants et des antécédents familiaux de maladies respiratoires."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les fumeurs et les personnes exposées."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires prédisposent-elles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de poumon hyperclair."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les allergies sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines allergies respiratoires peuvent contribuer à des problèmes pulmonaires, y compris l'hyperclarté."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 14/05/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
3 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Department of Transplant Center, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. daink@kuhp.kyoto-u.ac.jp.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Department of Transplant Center, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Department of Cardiothoracic Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, University of Florida, Gainesville, Florida, USA.
Publications dans "Poumon hyperclair" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, University of Florida Health, Gainesville, Florida, USA.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Hospital Universitario Puerta del Mar, Cádiz, España. jj_perezguerrero@hotmail.com.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Hospital Universitario Puerta del Mar, Cádiz, España.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Division of Pulmonary, Critical Care, and Sleep Medicine, University of Texas Health - McGovern Medical School, Houston, TX.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.
Publications dans "Poumon hyperclair" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Lenox Hill Hospital, New York, NY.
Publications dans "Poumon hyperclair" :
Neuropsychology is important in differential diagnosis, treatment planning, surgical work-up, and support of patients with movement disorders and their families. The cognitive profiles of several move...
On the basis of both scientific progress and popular lore, there is growing optimism in the therapeutic potential of cannabis (marijuana) and cannabinoid-based chemicals for movement disorders. There ...
In recognition of the high interest and controversial nature of this subject, the meeting committee of the International Parkinson and Movement Disorders Society arranged for a talk on cannabis at the...
The endocannabinoid system is strongly tied to motor function and dysfunction, with basic research suggesting several promising therapeutic targets related to cannabinoids for movement disorders. Clin...
Further research is greatly needed to better understand the actual clinical benefits and long-term side effects of medical cannabis products for movement disorders indications and populations....
Functional movement disorder (FMD) is a complex neuropsychiatric syndrome, encompassing abnormal movements and weakness, and is a common cause of potentially disabling neurological symptoms. It is vit...
Motor symptoms in functional movement disorders (FMDs) are experienced as involuntary but share characteristics of voluntary action. Clinical and experimental evidence indicate alterations in monitori...
The objective of this study was to test the prediction that FMDs are associated with a reduced ability to make accurate (metacognitive) judgments about self-performed movements....
We compared 24 patients with FMD (including functional gait disturbance, functional tremor, and functional tics) with 24 age- and sex-matched healthy control subjects in a novel visuomotor-metacogniti...
Patients and control subjects showed comparable motor performance, response accuracy, and use of the confidence scale. However, visuomotor sensitivity in the trajectory judgment was reduced in patient...
Patients with FMD exhibited deficits both when making visuomotor decisions about their own movements and in the metacognitive evaluation of these decisions. Reduced metacognitive insight into voluntar...
The purpose of this review is to outline the impact of the COVID-19 pandemic on movement disorder holistic care, particularly in the care of people with Parkinson disease (PWP)....
As the pandemic unfolds, a flurry of literature was published regarding the impact of COVID-19 on people with Parkinson disease including the direct impact of infection, availability of ambulatory car...
COVID-19 has impacted the care of PWP in numerous ways. Recognizing infection in PWP poses challenges. Specific long-term complications, including emerging reports of long COVID syndrome is a growing ...
Drug-induced movement disorders (DIMDs) are most commonly associated with typical and atypical antipsychotics. However, other drugs such as antidepressants, antihistamines, antiepileptics, antiarrhyth...
Post-stroke movement disorders (PSMD) encompass a wide array of presentations, which vary in mode of onset, phenomenology, response to treatment, and natural history. There are no evidence-based guide...
To survey current opinions and practices on the diagnosis and treatment of PSMD....
A survey was developed by the PSMD Study Group, commissioned by the International Parkinson's and Movement Disorders Society (MDS). The survey, distributed to all members, yielded a total of 529 respo...
Parkinsonism (68%), hemiballismus/hemichorea (61%), tremor (58%), and dystonia (54%) were by far the most commonly endorsed presentation of PSMD, although this varied by region. Basal ganglia stroke (...
Regionally varying opinions and practices on PSMD highlight gaps in (and mistranslation of) epidemiologic and therapeutic knowledge. Multicenter registries and prospective community-based studies are ...
The relationship between antiseizure drugs and movement disorders is complex and not adequately reviewed so far. Antiseizure drugs as a treatment for tremor and other entities such as myoclonus and re...
Hereditary or familial spastic paraplegias (SPG) comprise a group of genetically and phenotypically heterogeneous diseases characterized by progressive degeneration of the corticospinal tracts. The co...
To summarize the clinical descriptions of SPG that manifest with movement disorders or ataxias to assist the clinician in the task of diagnosing these diseases....
We conducted a narrative review of the literature, including case reports, case series, review articles and observational studies published in English until December 2022....
Juvenile or early-onset parkinsonism with variable levodopa-responsiveness have been reported, mainly in SPG7 and SPG11. Dystonia can be observed in patients with SPG7, SPG11, SPG22, SPG26, SPG35, SPG...
Patients with SPG may present with different forms of movement disorders such as parkinsonism, dystonia, tremor, myoclonus and ataxia. The specific movement disorder in the clinical manifestation of a...
Peripherally-induced movement disorders (PIMD) should be considered when involuntary or abnormal movements emerge shortly after an injury to a body part. A close topographic and temporal association b...
A comprehensive PubMed search through a broad range of keywords and combinations was performed in February 2023 to identify relevant articles for this narrative review....
The spectrum of the phenomenology of PIMD is broad and it encompasses both hyperkinetic and hypokinetic movements. Hemifacial spasm is probably the most common PIMD. Others include dystonia, tremor, p...
There is considerable heterogeneity among PIMD in terms of severity and nature of injury, natural course, association with pain, and response to treatment. As some patients may have co-existing functi...